Clinical Trial Update: Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating iberdomide alone or in combination with dexamethasone for intermediate- or high-risk smoldering multiple myeloma is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoldering Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• iberdomide (iberdomide)

Snippet

Sponsor: Emory University | Conditions: Smoldering Plasma Cell Myeloma | Phase 2 | Status: RECRUITING